Literature DB >> 11397789

Elevated levels of S-nitrosoalbumin in preeclampsia plasma.

V A Tyurin1, S X Liu, Y Y Tyurina, N B Sussman, C A Hubel, J M Roberts, R N Taylor, V E Kagan.   

Abstract

The availability of nitric oxide (NO), which is required for the normal regulation of vascular tone, may be decreased in preeclampsia, thus contributing to the vascular pathogenesis of this pregnancy disorder. Because ascorbate is essential for the decomposition of S-nitrothiols and the release of NO, we speculated that the ascorbate deficiency typical of preeclampsia plasma might result in decreased rates of decomposition of S-nitrosothiols. We tested the hypothesis that total S-nitrosothiol and S-nitrosoalbumin concentrations are increased in preeclampsia plasma, reflecting a decreased release of NO from these major reservoirs of NO. Gestationally matched plasma samples were obtained (before labor or intravenous MgSO(4)) from 21 women with preeclampsia and 21 women with normal pregnancy, and plasma samples were also obtained from 12 nonpregnant women of similar age and body mass index during the follicular phase of the menstrual cycle. All were nonsmokers. The assay included ultraviolet-induced decomposition of S-nitrosothiols to liberate NO captured by a florigenic reagent, 4,5-diaminofluoresceine, to produce diaminofluoresceine-Triazole. Preeclampsia plasma contained significantly higher concentrations of total S-nitrosothiols (11.1+/-2.9 nmol/mL) than normal pregnancy samples (9.4+/-1.5 nmol/mL). Even greater differences were found between preeclampsia plasma and plasma samples from normal pregnancies and nonpregnant women (294+/-110, 186+/-25, and 151+/-25 pmol/mg protein, respectively) when S-nitrosothiol content was expressed per milligram protein. The albumin fraction contained 49.4% of total plasma S-nitrosothiols in the control samples and 53.7% and 56.8% of plasma S-nitrosothiols in normal pregnancy and preeclampsia, respectively. The level of S-nitrosoalbumin was significantly higher in preeclampsia than in normal pregnancy or nonpregnancy plasma (6.3+/-1.4, 5.1+/-0.7, and 4.2+/-1.0 nmol/mL, respectively). The increased concentration of S-nitrosoalbumin in preeclampsia almost completely accounted for the increased levels of S-nitrosothiols in total plasma. Due to combined increases in nitrosothiols and decreases in protein, the preeclampsia plasma concentration of S-nitrosoalbumin was greatly increased on a per milligram of protein basis (271% and 186% compared with normal nonpregnancy and normal pregnancy plasma, respectively). We conclude that S-nitrosoalbumin and total S-nitrosothiol concentrations are significantly increased in preeclampsia plasma and may reflect insufficient release of NO groups in this condition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11397789     DOI: 10.1161/hh1101.092179

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  17 in total

Review 1.  S-nitrosothiols and the S-nitrosoproteome of the cardiovascular system.

Authors:  Bradley A Maron; Shiow-Shih Tang; Joseph Loscalzo
Journal:  Antioxid Redox Signal       Date:  2012-09-05       Impact factor: 8.401

Review 2.  Enzymatic mechanisms regulating protein S-nitrosylation: implications in health and disease.

Authors:  Puneet Anand; Jonathan S Stamler
Journal:  J Mol Med (Berl)       Date:  2012-02-24       Impact factor: 4.599

3.  Cytoprotective effects of albumin, nitrosated or reduced, in cultured rat pulmonary vascular cells.

Authors:  Hui-Hua Li; Jing Xu; Karla J Wasserloos; Jin Li; Yulia Y Tyurina; Valerian E Kagan; Xiaorong Wang; Alex F Chen; Zhao-Qian Liu; Detcho Stoyanovsky; Bruce R Pitt; Li-Ming Zhang
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-01-14       Impact factor: 5.464

4.  The Impact of Preeclampsia on Gene Expression at the Maternal-Fetal Interface.

Authors:  Virginia D Winn; Matthew Gormley; Susan J Fisher
Journal:  Pregnancy Hypertens       Date:  2011-01-01       Impact factor: 2.899

Review 5.  S-nitrosylation in cardiovascular signaling.

Authors:  Brian Lima; Michael T Forrester; Douglas T Hess; Jonathan S Stamler
Journal:  Circ Res       Date:  2010-03-05       Impact factor: 17.367

Review 6.  Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.

Authors:  Dania A Shah; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2015-04-24       Impact factor: 5.858

Review 7.  Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2.

Authors:  Virginia D Winn; Matthew Gormley; Agnes C Paquet; Kasper Kjaer-Sorensen; Anita Kramer; Kristen K Rumer; Ronit Haimov-Kochman; Ru-Fang Yeh; Michael T Overgaard; Ajit Varki; Claus Oxvig; Susan J Fisher
Journal:  Endocrinology       Date:  2008-09-25       Impact factor: 4.736

8.  S-nitrosothiol depletion in amyotrophic lateral sclerosis.

Authors:  Christopher M Schonhoff; Masaaki Matsuoka; Hemachand Tummala; Michael A Johnson; Alvaro G Estevéz; Rui Wu; Andrés Kamaid; Karina C Ricart; Yuichi Hashimoto; Benjamin Gaston; Timothy L Macdonald; Zuoshang Xu; Joan B Mannick
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-06       Impact factor: 11.205

Review 9.  Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy.

Authors:  Stephanie J Sheppard; Raouf A Khalil
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2010-03

Review 10.  Human placental microRNAs and preeclampsia.

Authors:  Dong-bao Chen; Wen Wang
Journal:  Biol Reprod       Date:  2013-05-23       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.